NLRX1: a key regulator in mitochondrial respiration and colorectal cancer progression

Y Ding, W Sun, M Han, Z Liu, H Kang, X Ma, J Wang… - Medical Oncology, 2024 - Springer
Colorectal cancer (CRC) is a prevalent and aggressive malignancy with high mortality rates
and significant risks to human well-being. Population-wide screening for tumor suppressor …

NLRX1 acts as an epithelial-intrinsic tumor suppressor through the modulation of TNF-mediated proliferation

I Tattoli, SA Killackey, EG Foerster, R Molinaro… - Cell reports, 2016 - cell.com
The mitochondrial Nod-like receptor protein NLRX1 protects against colorectal
tumorigenesis through mechanisms that remain unclear. Using mice with an intestinal …

NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells

MA Nagai-Singer, HA Morrison, MK Woolls… - Frontiers in …, 2023 - frontiersin.org
Pancreatic cancer is a deadly malignancy with limited treatment options. NLRX1 is a unique,
understudied member of the Nod-like Receptor (NLR) family of pattern recognition receptors …

[HTML][HTML] NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells

K Singh, A Poteryakhina, A Zheltukhin… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Chronic inflammation in tumor microenvironment plays an important role at different stages
of tumor development. The specific mechanisms of the association and its role in providing a …

NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer

R Karki, RKS Malireddi, Q Zhu, TD Kanneganti - Cell Cycle, 2017 - Taylor & Francis
Nucleotide-binding domain, leucine-rich-repeat–containing proteins (NLRs) are intracellular
innate immune sensors of pathogen-associated and damage-associated molecular patterns …

Low NLRP3 expression predicts a better prognosis of colorectal cancer

F Shi, B Wei, T Lan, Y Xiao, X Quan, J Chen… - Bioscience …, 2021 - portlandpress.com
Background: NOD-like receptor pyrin domain-3 (NLRP3) inflammasome activation is a
double-edged sword in tumorigenesis. Whether NLRP3 is involved in the progression and …

Comprehensive analysis of the role of NLRC5 in gastrointestinal cancer: a systematic review

N Rahadiani, M Ghozali, DL Dewi - Universa Medicina, 2024 - univmed.org
Background Gastrointestinal (GI) cancer is affecting millions of people globally, leading to
high incidence and mortality rates and a heavy economic burden. Nucleotide-binding …

[HTML][HTML] NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells

K Singh, M Roy, P Prajapati, A Lipatova… - … et Biophysica Acta (BBA …, 2019 - Elsevier
An increased level of proinflammatory cytokines, including TNF-α in tumor microenvironment
regulates the bioenergetic capacity, immune evasion and survival of cancer cells. Emerging …

NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway

H Yin, G Sun, Q Yang, C Chen, Q Qi, H Wang, J Li - Scientific Reports, 2017 - nature.com
Nucleotide-binding domain and leucine-rich-repeat-containing family member X1 (NLRX1),
located in mitochondria, can recognize cytoplasmic pattern recognition receptors and is …

[HTML][HTML] NLRC3 inhibits mTOR in colorectal cancer

O Leavy - Nature Reviews Immunology, 2017 - nature.com
NLRC3 inhibits mTOR in colorectal cancer | Nature Reviews Immunology Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …